Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Nvidia and Micron are excellent ways to invest in AI. Airbnb and Vertex Pharmaceuticals are two growth stocks that are worth a closer look. Enterprise Products Partners can be a passive-income ...

From GPS navigation systems to images of current events taking place on the other side of the planet, the world in 3D is ...

Nvidia (NVDA) CEO Jensen Huang took to the stage Tuesday afternoon to deliver his keynote speech at the chip giant's 2025 GTC event (GPU Technology Conference), where he previewed the company's ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

PALO ALTO, California/HONG KONG -- TikTok is attempting to hammer out a deal with the Trump administration that would resolve the sale-or-ban order while leaving control of the platform in the ...

This is the kind of game where halting your movement for even a split second often means being instantly overwhelmed by enemies that swarm from all angles. Rather than being hard to handle ...

As of 3:23:43 PM EDT. Market Open.